Furthermore, a previous study demonstrated that, to prevent the detrimental effects of EPO, the treatment of anemia in chronic renal failure usually requires low doses of EPO between 350 and 400 units or less on a very repetitive base over several weeks or months (27). This evidence concerns the gene EPO and anemia.